BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...three —respectively from University of Nottingham, University of California Santa Barbara...
...Medical School Zhejiang University School of Medicine University of Nottingham University of California Santa Barbara Trypanosoma...
BioCentury | May 1, 2020
Distillery Therapeutics

A low-density lipoprotein receptor identified as tauopathy target

...published online April 1, 2020 doi:10.1038/s41586-020-2156-5 CONTACT: Kenneth S. Kosik, University of California Santa Barbara, Santa Barbara, Calif. email: kenneth.kosik@lifesci.ucsb.edu Claire...
BioCentury | Nov 6, 2014
Distillery Techniques

Technology: Drug platforms

...California, Santa Barbara, Calif. e-mail: mtsoh@engr.ucsb.edu Contact: Craig J. Hawker, same affiliation as above e-mail: hawker@mrl.ucsb.edu BC...
BioCentury | Sep 29, 2014
Finance

Avalon-GSK bet on familiarity, speed

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Avalon Ventures' double launch of iron play Silarus Therapeutics Inc. and autoimmune company Thyritope Biosciences Inc. shows one more element the pharma likes about the partnership's 2013 deal to fund...
BioCentury | Mar 17, 2014
Clinical News

Bexsero regulatory update

Novartis said that the Australian Technical Advisory Group on Immunisation (ATAGI) recommended the use of Bexero to vaccinate children ages <=2 years and adolescents ages 15-19 years against meningitis B. The advisory group provides advice...
BioCentury | Mar 3, 2014
Clinical News

Bexsero regulatory update

...which has had 4 confirmed cases of the disease since November. The vaccination program at UCSB...
BioCentury | Jan 16, 2014
Distillery Techniques

Technology: Instrumentation

...Nov. 27, 2013; doi:10.1126/scitranslmed.3007095 Contact: Hyongsok Tom Soh, University of California, Santa Barbara, Calif. e-mail: tsoh@engr.ucsb.edu BC...
BioCentury | Jul 18, 2013
Distillery Techniques

Technology: Drug delivery

...online June 10, 2013; doi:10.1073/pnas.1308345110 Contact: Samir Mitragotri, University of California, Santa Barbara, Calif. e-mail: samir@engr.ucsb.edu...
BioCentury | Jul 18, 2013
Distillery Therapeutics

Indication: Neurology

...June 4, 2013; doi:10.1074/jbc.M112.436402 Contact: Kenneth S. Kosik, University of California, Santa Barbara, Calif. e-mail: kenneth.kosik@lifesci.ucsb.edu BC...
BioCentury | Sep 27, 2012
Tools & Techniques

Slipping therapeutics to the mitochondria

Researchers from The University of Georgia have developed a polymeric nanoparticle technology that can selectively deliver small molecules to the mitochondria of cultured cells. 1 The researchers now are evaluating the nanoparticles in animal models...
Items per page:
1 - 10 of 37
BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...three —respectively from University of Nottingham, University of California Santa Barbara...
...Medical School Zhejiang University School of Medicine University of Nottingham University of California Santa Barbara Trypanosoma...
BioCentury | May 1, 2020
Distillery Therapeutics

A low-density lipoprotein receptor identified as tauopathy target

...published online April 1, 2020 doi:10.1038/s41586-020-2156-5 CONTACT: Kenneth S. Kosik, University of California Santa Barbara, Santa Barbara, Calif. email: kenneth.kosik@lifesci.ucsb.edu Claire...
BioCentury | Nov 6, 2014
Distillery Techniques

Technology: Drug platforms

...California, Santa Barbara, Calif. e-mail: mtsoh@engr.ucsb.edu Contact: Craig J. Hawker, same affiliation as above e-mail: hawker@mrl.ucsb.edu BC...
BioCentury | Sep 29, 2014
Finance

Avalon-GSK bet on familiarity, speed

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Avalon Ventures' double launch of iron play Silarus Therapeutics Inc. and autoimmune company Thyritope Biosciences Inc. shows one more element the pharma likes about the partnership's 2013 deal to fund...
BioCentury | Mar 17, 2014
Clinical News

Bexsero regulatory update

Novartis said that the Australian Technical Advisory Group on Immunisation (ATAGI) recommended the use of Bexero to vaccinate children ages <=2 years and adolescents ages 15-19 years against meningitis B. The advisory group provides advice...
BioCentury | Mar 3, 2014
Clinical News

Bexsero regulatory update

...which has had 4 confirmed cases of the disease since November. The vaccination program at UCSB...
BioCentury | Jan 16, 2014
Distillery Techniques

Technology: Instrumentation

...Nov. 27, 2013; doi:10.1126/scitranslmed.3007095 Contact: Hyongsok Tom Soh, University of California, Santa Barbara, Calif. e-mail: tsoh@engr.ucsb.edu BC...
BioCentury | Jul 18, 2013
Distillery Techniques

Technology: Drug delivery

...online June 10, 2013; doi:10.1073/pnas.1308345110 Contact: Samir Mitragotri, University of California, Santa Barbara, Calif. e-mail: samir@engr.ucsb.edu...
BioCentury | Jul 18, 2013
Distillery Therapeutics

Indication: Neurology

...June 4, 2013; doi:10.1074/jbc.M112.436402 Contact: Kenneth S. Kosik, University of California, Santa Barbara, Calif. e-mail: kenneth.kosik@lifesci.ucsb.edu BC...
BioCentury | Sep 27, 2012
Tools & Techniques

Slipping therapeutics to the mitochondria

Researchers from The University of Georgia have developed a polymeric nanoparticle technology that can selectively deliver small molecules to the mitochondria of cultured cells. 1 The researchers now are evaluating the nanoparticles in animal models...
Items per page:
1 - 10 of 37